Related Experiment Video

Updated: Jul 18, 2026

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions
09:11

Caffeine Extraction, Enzymatic Activity and Gene Expression of Caffeine Synthase from Plant Cell Suspensions

Published on: October 2, 2018

Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression

S N Williams1, H Shih, D K Guenette

  • 1Section of Medical Toxicology, Department of Medicine, University of Colorado Health Sciences Center, B146, 4200 East 9th Avenue, 80262, Denver, CO, USA.

Chemico-Biological Interactions
|November 7, 2000
PubMed

Insights

Green tea extracts (GTEs) modulate the aryl hydrocarbon receptor (AhR) and CYP1A gene expression. GTEs show mixed agonist/antagonist activity, while EGCG acts as an antagonist, suggesting complex interactions for cancer prevention.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Green tea exhibits anticancer properties in animal models.
  • The aryl hydrocarbon receptor (AhR) is involved in regulating genes like CYP1A1 and CYP1A2.
  • Understanding green tea's mechanism against aryl hydrocarbon-induced cancers is crucial.

Purpose of the Study:

  • To investigate the effects of green tea extracts (GTEs) and catechins on AhR function.
  • To analyze the impact on CYP1A gene expression in human liver cells.
  • To elucidate the role of specific green tea components in modulating AhR activity.

Main Methods:

  • Utilized human hepatoma HepG2 cells and primary human hepatocytes.
  • Assessed reporter gene activity for CYP1A1 promoter.
  • Measured CYP1A1 and CYP1A2 mRNA levels via quantitative methods.
  • Investigated AhR binding to DNA in cellular and in vitro systems.
  • Examined individual catechins, including EGCG, for their effects.

Main Results:

  • GTEs inhibited TCDD-induced CYP1A1 transcription and mRNA accumulation in a dose-dependent manner.
  • GTEs blocked TCDD-induced AhR binding to DNA.
  • (-)-Epigallocatechin gallate (EGCG) inhibited AhR-DNA binding and CYP1A transcription but was less potent than GTEs.
  • GTEs exhibited mixed agonist/antagonist activity on AhR, while EGCG acted as a pure antagonist.
  • Individual catechins did not induce CYP1A1 expression, unlike GTEs.

Conclusions:

  • Green tea extracts modulate human CYP1A expression through complex interactions, not a single catechin.
  • EGCG acts as an AhR antagonist, contributing to the overall effect of GTEs.
  • The findings support the potential of green tea as a cancer preventive agent through AhR pathway modulation.

More Related Videos

Study on the Metabolism of Six Systemic Insecticides in a Newly Established Cell Suspension Culture Derived from Tea (Camellia Sinensis L.) Leaves10:35

Study on the Metabolism of Six Systemic Insecticides in a Newly Established Cell Suspension Culture Derived from Tea (Camellia Sinensis L.) Leaves

Published on: June 15, 2019

Tea Aroma Analysis Based on Solvent-Assisted Flavor Evaporation Enrichment04:36

Tea Aroma Analysis Based on Solvent-Assisted Flavor Evaporation Enrichment

Published on: May 26, 2023

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Reporter Genes02:11

Reporter Genes

Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview01:27

Pharmacogenetics of Drug Metabolism: Overview

Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...